VA North Texas Health Care System is seeking a contractor to provide laboratory services.
SUPPLIES OR SERVICES
The purpose of this contract is to provide to veteran patients quality laboratory services. Contractor is to provide healthcare resources in accordance with Public Law 104.262 and 38 U.S.C. 8153. Contractor agrees to provide the following laboratory procedures/tests in support of the VA North Texas Health Care System (VANTHCS) in Dallas, Texas.
Pricing includes all labor, materials, equipment and supplies necessary to perform certain human laboratory procedures/tests.
Contractor shall perform and provide results for, but not limited to, the following procedures/tests. Additional tests may be added or removed as needed during contract period as required.
Reference Lab Test Items
as of 7/3/2018
B
B
B
B
B
Turn Around
Perform Lab
Detail Charge Description
Order Mnemonic
CPT Code
B
CoPath
88341 IHC, each add'l per specimen
NP
88341
B
CoPath
88341 IHC, each add'l per specimen
IHC
88341
B
VIROLOGY
ADENOVIRUS ANTIBODY
VADEN
86603
B
VIROLOGY
B
VARBGM
B
B
VIROLOGY
CALIFORNIA (LACROS) ENCEP
VARBGM
86651
B
VIROLOGY
CALIFORNIA VIRAL ANTIBODY IGG
VARBGM
86651
B
VIROLOGY
EASTERN EQUINE ENCEP
VARBGM
86652
B
VIROLOGY
EASTERN EQUINE ENCEPH AB
VARBGM
86652
B
VIROLOGY
ST LOUIS ENCEPH IGG TITER
VARBGM
86653
B
VIROLOGY
ST LOUIS ENCEPH IGM TITER
VARBGM
86653
B
VIROLOGY
WESTERN EQUINE ENCEP
VARBGM
86654
B
VIROLOGY
WEST EQ ENCEPHALITIS VIRAL ANT
VARBGM
86654
B
AP
Process block + H&E
IHC
978068
B
VIROLOGY
CALIFORNIA VIRAL ANTIBODY IGG
VCAEG
86651
B
VIROLOGY
B
VCMVAG
B
B
VIROLOGY
SPIN FLUID CONCENTRATION
VCMVAG
87015
B
VIROLOGY
CMV BY DFA ANTIGENEMIA
VCMVAG
87271
B
VIROLOGY
B
VCMVC
B
B
VIROLOGY
CYTOMEGALOVIRUS CULTURE
VCMVC
87252
B
VIROLOGY
B
VCMVGM
B
B
VIROLOGY
CMV IGG TITER
VCMVGM
86644
B
VIROLOGY
CMV IGM TITER
VCMVGM
86645
B
VIROLOGY
CMV IGG TITER
VCMVG
86644
B
VIROLOGY
CMV IGM TITER
VCMVM
86645
B
CoPath Default
88325 Consult, comprehensive
NP
88325
B
CoPath Default
88325 Consult comprehensive
NP
88325
B
CoPath Default
88325 Consult comprehensive
IHC
88325
B
AP
Dystrophin panel 88342x4
IHC
88342
1 day
CoPath
88344 each multiplex antibody stain procedure
IHC
88344
1 day
CoPath
88344 each multiplex antibody stain procedure
NP
88344
1 day
CoPath
88344 IHC multiplex, per specimen
IHC
88344
1 day
CoPath
88344 IHC multiplex, per specimen
NP
88344
B
VIROLOGY
EASTERN EQUINE ENCEPH AB
VEEEG
86652
B
VIROLOGY
EASTERN EQUINE ENCEPH AB
VEEEM
86652
B
VIROLOGY
EBV VIRAL CAPSID IGM
VEBVM
86665
B
VIROLOGY
EB VIRUS EARLY ANTIGEN
VEBVEA
86663
B
VIROLOGY
EBV EARLY ANTIGEN
VEBVNA
86664
B
VIROLOGY
EBV VIRAL CAPSID IGG
VEBVG
86665
B
VIROLOGY
B
VEBV
B
B
VIROLOGY
EB VIRUS EARLY ANTIGEN
VEBV
86663
B
VIROLOGY
EPSTEIN-BARR EBNA IFA
VEBV
86664
B
VIROLOGY
EBV VIRAL CAPSID IGM
VEBV
86665
B
VIROLOGY
EBV VIRAL CAPSID IGG
VEBV
86665
B
CoPath
88348-52 Electron Microscopy: Embed only
NP
88348-52
B
CoPath
88348 Electron Microscopy: Complete
NP
88348
B
CoPath
88348-52 Electron Microscopy: Embed and
NP
88348-52
B
CoPath
88348-52 Electron Microscopy: Embed only
IHC
88348-52
B
CoPath
88348 Muscle Bx,Electron Microscopy
NP
88348
B
CoPath
88348 Muscle Bx,Electron Microscopy
IHC
88348
B
CoPath
88348 Electron Microscopy: Complete
IHC
88348
B
CoPath
88348-52 Electron Microscopy: Embed and
IHC
88348-52
B
MOLECULAR
MFVLED
MFVLED
81241
B
AP
Frozen section, first block
IHC
88331
B
AP
Hematoxylin & eosin
IHC
978069
B
MICRO BIOLOGY
HERPES SIMPLEX CULTURE
VHSVC
87252
B
VIROLOGY
B
VHSVIG
B
B
VIROLOGY
HSV I IGG TITER
VHSVIG
86695
B
VIROLOGY
HSV II IGG TITER
VHSVIG
86696
B
VIROLOGY
HERPES SIMPLEX 1 AG, IF
VHSV1D
87274
B
VIROLOGY
HSV I IGG TITER
VHSVG
86695
B
VIROLOGY
HSV 2 IGG TITER
VHSVG2
86696
B
VIROLOGY
HSV 2 IGM TITER
VHSVM2
86694
B
VIROLOGY
HERPES SIMPLEX 1 AG, IF
VHSV1A
87274
B
MICRO BIOLOGY
B
VHSVFA
B
B
MICRO BIOLOGY
HERPES SIMPLEX 1 AG, IF
VHSVFA
87274
6 days
CoPath
88361 Image Analysis - Computer Assisted
NP
88361
6 days
CoPath
88361-Image Asstd Morph Analy-Tumor
NP
88361
6 days
CoPath
88361 Image Asstd Morph Analy-Tumor
NP
88361
6 days
CoPath
88360 Image Analysis - Manual
NP
88360
6 days
CoPath
88347 Immunofluorescence - Indirect
NP
88347
6 days
CoPath
88342 Immunohistochemistry - IHC
NP
88342
6 days
CoPath
88342 Immunohistochemistry - IHC
IHC
88342
6 days
CoPath
88342 IHC, initial per specimen
NP
88342
6 days
CoPath
88342 IHC, initial per specimen
IHC
88342
6 days
CoPath
88343 Immunohisto Antibod Add Stain1 - s
IHC
88343
6 days
CoPath
88343 Immunohisto Antibod Add Stain1 - s
NP
88343
6 days
CoPath
88364 Insitu Hybridization Each Addtl Probe
NP
88364
6 days
CoPath
88364 ISH, each add'l per specimen
NP
88364
6 days
CoPath
88365 Insitu Hybridization Each Probe
NP
88365
6 days
CoPath
88365 ISH, initial, each probe per speci
NP
88365
6 days
CoPath
88364 Insitu Hybridization Each Addtl Probe
IHC
88364
6 days
CoPath
88364 ISH, each add'l per specimen
IHC
88364
6 days
CoPath
88365 Insitu Hybridization Each Probe
IHC
88365
6 days
CoPath
88365 ISH, initial, each probe per speci
IHC
88365
B
VIROLOGY
EIA QL MLT AG
VULGNL
87449
B
CoPath
88305 Muscle Biopsy
NP
88305
B
CoPath
88305 Muscle Biopsy
IHC
88305
B
VIROLOGY
MEASLES IGG TITER
VMEASG
86765
B
VIROLOGY
MEASLES IGM TITER
VMEASM
86765
B
VIROLOGY
B
VMVC
B
B
VIROLOGY
MISC VIRAL CULTURE
VMVC
87252
B
VIROLOGY
INTERFERON NEUTRAL. ABY
VMVC
87253
B
AP
Morphometric analysis, in situ hybridization, manual
NP
88368
B
VIROLOGY
MUMPS IGG TITER
VMUMPG
86735
B
VIROLOGY
MUMPS IGM TITER
VMUMPM
86735
B
CoPath
88314 Muscle/Nerve Bx,Histochem 88314
NP
88314
B
CoPath
88314 Muscle/Nerve BxHistochem 88314
NP
88314
B
VIROLOGY
MYCOPLASMA IGG TITER
VMYCOG
86738
B
VIROLOGY
MYCOPLASMA IGM TITER
VMYCOM
86738
B
CoPath
88319 Nerve BxAddnl Det Enz Histochem
NP
88319
B
CoPath
88319 Nerve BxAddnl Det Enz Histochem
NP
88319
B
MICRO BIOLOGY
B
VPCPS
B
B
MICRO BIOLOGY
SPIN FLUID CONCENTRATION
VPCPS
87015
B
MICRO BIOLOGY
PNEUMOCYSTIS STAIN
VPCPS
87281
B
AP
ProcessBlock
IHC
88399
B
MOLECULAR
MPROTH
MPROTH
B
B
MOLECULAR
MPROTH
MPROTH
81240
B
MICRO BIOLOGY
RSV SCREEN
VRSV
87280
B
CoPath Default
88312 Special Stain Micro
NP
88312
B
CoPath
88313 Muscle Bx,Histochem
IHC
88313
B
CoPath
88313 Special Stain
IHC
88313
B
CoPath
88313 Muscle Bx,Histochem
NP
88313
B
CoPath
88313 Special Stain
NP
88313
B
CoPath
88319 Special Stains Group III, enzyme constituents
NP
88319
B
CoPath Default
88319 Special Stains Group III, enzyme c
NP
88319
B
CoPath Default
88319 Special Stains Group III, enzyme c
NP
88319
B
CoPath
88319 Special Stains Group III, enzyme constituents
NP
88319
B
VIROLOGY
ST LOUIS ENCEPH IGG TITER
VSLEG
86653
B
VIROLOGY
ST LOUIS ENCEPH IGM TITER
VSLEM
86653
B
CoPath
88362 NerveBx, Teased Fiber Prep
NP
88362
B
CoPath
88362 NerveBxTeased Fiber Prep
NP
88362
B
CoPath
88362 NerveBx,Teased Fiber Prep
NP
88362
B
AP
Unstained sections
IHC
978070
B
Draw Stn
VENIPUNCTURE
DVP
36415
B
Draw Stn
VENIPUNCTURE
DVP
36415
B
VIROLOGY
VZV IGG TITER
VVZVG
86787
B
VIROLOGY
VGV IGM TITER
VVZVM
86787
B
VIROLOGY
B
VWNEC
B
B
VIROLOGY
WEST NILE VIRUS IGG ANTIBODY
VWNEC
86788
B
VIROLOGY
WEST NILE VIRUS IGG IGM
VWNEC
86789
B
HEMOSTASIS
B
VWBPLX
B
B
HEMOSTASIS
FIBRIN OR COAG SCRN W I&R
VWBPLX
85390
B
HEMOSTASIS
2 MICRO G COLLAGEN
VWBPLX
85576
B
VIROLOGY
WEST EQ ENCEPHALITIS VIRAL ANT
VWEEG
86654
B
VIROLOGY
B
VWNE
B
B
VIROLOGY
WEST NILE VIRUS IGG ANTIBODY
VWNE
86788
B
VIROLOGY
WEST NILE VIRUS IGG IGM
VWNE
86789
B
VIROLOGY
WEST NILE VIRUS IGG ANTIBODY
VWNEMR
86788
3 days
CYTOGENETICS
Chromosome Analysis (Bone Marrow) *Specimen must arrive at laboratory within 24 hrs.
B
B
6 days
CYTOGENETICS
FISH STUDIES
B
B
B
Reproductive Endocrinology
Semen Analysis ***Patient reports to RE lab to collect and submit specimen. Specimen must be tested within one hour of collection.
B
B
1-3 days
HEMOSTASIS
Platelet Aggregation - specimen must arrive at laboratory within 1 hr. of collection.
B
B
STATEMENT OF WORK
Contractor shall provide laboratory services to the Pathology & Laboratory Medicine Service of the VA North Texas Health Care System, Department of Veterans Affairs Medical Center, located at 4500 S. Lancaster Road, Dallas, Texas. Tests will be performed as prescribed by the VA attending physician.
Contractor shall provide laboratory services to include daily scheduled specimen transportation, analysis and reporting of analytic results, and consultation regarding selection, collection, transportation and result interpretation. Results are to be accessible through the contractor s electronic database by P&LMS personnel.
Contractor will supply test kits, collection containers, and specimen transport supplies. Supplies will be delivered at no charge at the request of P&LMS personnel and/or through vendor s automated inventory system.
Contract shall cover a period from October 1, 2018 through September 30, 2023. Contract will be renewable for (4) option years. Pricing will be provided for the base year and each option year.
Base Period TBD
Option 1 October 1, 2019 through September 30, 2020
Option 2 October 1, 2020 through September 30, 2021
Option 3 October 1, 2021 through September 30, 2022
Option 4 October 1, 2022 through September 30, 2023
VA North Texas Health Care System (VANTHCS) may award multiple contracts. The test and/or volumes listed are independent government estimates and VANTHCS makes no guarantee as to what volume of tests, if any, the contractor may receive. VANTHCS reserves the right to request additional tests other than those listed within. If additional tests are added, either by the contractor or VANTHCS, the contractor will provide appropriate CPT codes for the new tests.
Contractor shall provide all labor, equipment, and materials required to perform procedures/tests as stated herein.
These procedures/tests shall be performed to the satisfaction of VA North Texas Health Care System (VANTHCS) Pathology & Laboratory Medicine Service, Chief of Staff, and the Contracting Officer s Technical Representative (COTR).
Services rendered will be verified by a record keeping system maintained by Pathology & Laboratory Medicine Service and Fiscal Service at VANTHCS, which assures that the VA pays for only those services actually requested, and only for valid patients of VANTHCS.
Contractor shall provide to the COTR the methodology and ranges for results on any tests that are requested.
Security Requirements: VA Protected Health Information is provided to the vendor under this contract. This contract is to enable a HIPAA Covered Entity to provide clinical services on behalf of VA.B B A patient s consent is not required (1605.1P24).B The vendor is required to secure the PHI as required by HIPAA.
SECTION B: DESCRIPTION/SPECIFICATIONS
DEFINITIONS:
LAB ADVISORY COMMITTEE: An individual or group of laboratory directors (Chiefs) or their designees that evaluate the medical/technical/service/quality qualifications of offerors labs. During the life of the contract, this group monitors the quality and service provided by the contractor.
SPECIAL HANDLING: Unusual circumstances may dictate the need for a specimen to be picked up specially, run out of sequence or at a special time, or reported within a shorter than usual time.
CONTRACTING OFFICER: The Contracting Officer (CO) named below is responsible for the overall administration of this contract. Contractor is advised that only the Contracting Officer, acting within the scope of his/her duties and responsibilities, has the authority to make changes to the contract, which affect contract prices, terms and conditions of this contract:
VA North Texas Health Care System
Contracting Officer 90C
4500 S. Lancaster Road
Dallas, Texas 75216
Roseburg OR 97470
(214) 857-0036
CONTRACTING OFFICER TECHNICAL REPRESENTATIVE: A Technical Representative of the Contracting Officer (COTR) will be designated to represent the Contracting Officer in furnishing technical guidance and advice under this contract. The foregoing is not to be construed as authorization to interpret or furnish advice and information to Contractor relative to the financial or legal aspects of the contract. Those matters are the responsibility of the Contracting Officer and shall not be delegated.
LAB REPORTS: All lab reports shall contain at a minimum the following information:
Patient s full name
Physician name
Type of specimen
Patient s Social Security Number
Patient Date of Birth
Requesting Facility
REPORTING OF LAB REPORTS RESULTS: All lab reports shall be reported via fax, and a hard copy of all lab results shall be sent via courier. In extenuating circumstances which will not allow for the Contractor to report results via fax or sent by courier, reports can be reported via mail.
CLINIC CONTACTS: Contractor shall consult with the VANTHCS Laboratory Manager on test results via phone as needed. The contractor can contact the providers at: (214) 857-0666.
CONTRACTOR POINT OF CONTACT: Contractor shall provide the following point (s) of contact when immediate inquiry regarding the status of a pending test (s) is required:
A) Person (s) name (s): ____________________________________________________
B) Telephone number: ____________________________________________________
C) Fax number: _________________________________________________________
PAYMENT: The VA shall not be responsible for payment for services which were not requested in accordance with contract.
TRANSPORTATION OF SPECIMENS: Contractor shall transport specimens in such a manner as to ensure the integrity of the specimen. Frozen specimens shall be shipped on dry ice, provided by contractor. Contractor is also responsible for completing hazardous goods forms and proper labeling.
LICENSING AND ACCREDITATION:
Contractor shall have all licenses, permits, accreditation and certificates required by law.
Personnel assigned by the contractor to perform these services covered under this contract shall be licensed in a State, Territory or Commonwealth of the United States or the District of Columbia.
The lab must be accredited by the College of American Pathologist (CAP) or have JCAHO and Clinical Laboratory Improvement Amendments (CLIA) (Public Law 100-578) certifications or C LIA waiver. Contractor must submit proof of JCAHO and CLIA certifications/waiver along with their offer.
Laboratory Director shall be a licensed pathologist, physician, or biologist.
By the end of each month following the end of the quarter, the contractor shall provide to the Laboratory Manager and COR a cumulative (year-to-date) summary report by test. The report shall include at minimum the following
Number of tests performed
Number of test rejections with reason for rejection
TAT for each test order during that quarter
The VA shall have access to inspect the contractor s facilities, equipment and records. The results of these inspections shall be published and given to the contractor.
Contractor shall immediately advise the Laboratory Manager and COR of any changes in methodology, procedure, reference ranges and any new test introduced, including CPT code.
Contractor shall provide the following information annually during the life of the contract:
Indication of average monthly volume of specified tests listed in this contract.
Provide address of processing sites under contract, including subcontracted testing location sites.
Proficiency testing data shall include a list of tests outside of the -+2SD range for the past two (2) years. Contractor shall notify lab of any test falling outside -+2SD range during contract period.
Contractor agrees to maintain the satisfactory service, reporting systems and quality control as specified herein. Acceptable performance will be determined annually by the criteria listed below.
Scoring Average score value per category:
Exceptional 4
Very Good 3
Satisfactory 2
Marginal 1
Unsatisfactory
